T-cell depletion

Key takeaways

T-cell depletion belongs to biology; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect T-cell depletion to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of T-cell depletion from memory before moving on to harder problems.

Reference excerpt

T-cell depletion (TCD) is the process of T cell removal or reduction, which alters the immune system and its responses. Depletion can occur naturally (i.e. in HIV) or be induced for treatment purposes. TCD can reduce the risk of graft-versus-host disease (GvHD), which is a common issue in transplants. The idea that TCD of the allograft can eliminate GvHD was first introduced in 1958. In humans the first TCD was performed in severe combined immunodeficiency patients.

Depletion methods T cell depletion methods can be broadly categorized into either physical or immunological. Examples of physical separation include using counterflow centrifugal elutriation, fractionation on density gradients, or the differential agglutination with lectins followed by rosetting with sheep red blood cells. Immunological methods utilize antibodies, either alone, in conjunction with homologous, heterologous, or rabbit complement factors which are directed against the T cells. In addition, these techniques can be used in combinations. These techniques can be performed either in vivo, ex vivo, or in vitro. Ex vivo techniques enable a more accurate count of the T cells in a graft and also has the option to 'addback' a set number of T cells if necessary. Currently, ex vivo techniques most commonly employ positive or negative selection methods using immunomagnetic separation. In contrast, in-vivo TCD is performed using anti-T cell antibodies or, most recently, post-HSCT cyclophosphamide. The method by which depletion occurs can heavily affect the results. Ex vivo TCD is predominantly used in GvHD prevention, where it offers the best results. However, complete TCD via ex vivo, especially in acute myeloid leukemia (AML), patients usually does not improve survival. In vivo depletion often uses monoclonal antibodies (eg, alemtuzumab) or heteroantisera. In haploidentical hematopoietic stem cell transplantation, in vivo TCD suppressed lymphocytes early on. However, the incidence rate of cytomegalovirus (CMV) reactivations is elevated. These problems can be overcome by combining TCD haploidentical graft with post-HSCT cyclophosphamide. In contrast, both in vivo TCD with alemtuzumab and in vitro TCD with CD34+ selection performed comparably. Although TCD can be effective in preventing GvHD, there are several potential problematic side-effects such as a delay in recovery of the immune system of the transplanted individual or a decreased graft-versus-tumor effect. This problem is partially answered by more selective depletion, such as depletion of CD3+ or TCRα/β+ T-cells and CD19+ B cells, which preserves other important cells of the immune system. Another method is addition of cells back into the graft, after a comprehensive TCD method, examples are re-introduction of natural killer cells (NK), γδ T-cells and T regulatory cells (Tregs). Early on it was apparent that TCD was good for preventing GvHD, but also led to increased graft rejection; this problem can be solved by transplanting more hematopoietic stem cells. This procedure is called 'megadose transplantation,' and can prevent rejection because the stem cells have the ability to protect themselves from the host's immune system (i.e. veto cell killing). Experiments show that transplantation of other types of veto cells along with megadose haploidentical HSCT reduces the toxicity of the conditioning regimen, which makes this treatment much safer and more applicable to many diseases. These veto cells can also exert graft-versus-tumor effect.

Role in disease

In HIV HIV has been confirmed to target CD4+ T cells and destroy them, making T cell depletion an important hallmark of HIV. In comparison to HIV- individuals, CD4+ T cells proliferate at a higher rate in those who are HIV+. Apoptosis also occurs more frequently in HIV+ patients. Depletion of regulatory T cells increases immune activation. Glut1 regulation is associated with the activation of CD4+ T cells, thus its expression can be used to track the loss of CD4+ T cells during HIV. Antiretroviral therapy, the most common treatment for patients with HIV, has been shown to restore CD4+ T cell counts. The body responds to T cell depletion by producing an equal amount of T cells. However, over time, an individual's immune system can no longer continue to replace CD4+ T cells. This is called the "tap and drain hypothesis."

In cancer TCD's role in cancer increasing with the rise of immunotherapies being investigated, specifically those that target self-antigens. One example is antigen-specific CD4+ T cell tolerance, which serves as the primary mechanism restricting immunotherapeutic responses to the endogenous self antigen guanylyl cyclase c (GUCY2C) in colorectal cancer. However, in some cases, selective CD4+ T cell tolerance provides a unique therapeutic opportunity to maximize self antigen-targeted immune and antitumor responses without inducing autoimmunity by incorporating self antigen-independent CD4+ T cell epitopes into cancer vaccines. In a mammary carcinoma model, depletion of CD25+ regulatory T cells increase the amount of CD8+CD11c+PD110, which target and kill the tumors.

In lupus Phenotypic and functional characteristics of regulatory T cells in lupus patients do not differ from healthy patients. However, depletion of regulatory T cells results in more intense flares of systemic lupus erythematosus. The in vivo depletion of regulatory T cells is hypothesized to occur via early apoptosis induction, which follow exposure to self Ags that arise during the flare.

In murine cytomegalovirus (MCMV) infection MCMV is a rare herpesvirus that can cause disseminated and fatal disease in the immunodeficient animals similar to the disease caused by human cytomegalovirus in immunodeficient humans. Depletion of CD8+ T cells prior to a MCMV infection effectively upregulates the antiviral activity of natural killer cells. Depletion post infection has no effect on the NK cells.

In arthritis A preliminary study of the effect on TCD in arthritis in mice models has shown that regulatory T cells play an important role in delayed-type hypersensitivity arthritis (DTHA) inflammation. This occurs by TCD inducing increased neutrofils and activity of IL-17 and RANKL.

Treatment use

… excerpt ends here. Continue reading the full article.

Worked examples

Example 1 — a first encounter with T-cell depletion

Start with the simplest possible case. Write down what T-cell depletion claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to T-cell depletion before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about T-cell depletion ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of T-cell depletion

In research: T-cell depletion appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses T-cell depletion in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: T-cell depletion is common in secondary-school and first-year university syllabi. It links to neighbouring topics Immune system, T cells, so understanding it makes those chapters shorter.
In everyday life: Look for T-cell depletion outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

How to study T-cell depletion in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what T-cell depletion means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain T-cell depletion out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is T-cell depletion in simple terms?

T-cell depletion (TCD) is the process of T cell removal or reduction, which alters the immune system and its responses. Depletion can occur naturally (i.e. in HIV) or be induced for treatment purposes.

Why does T-cell depletion matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study T-cell depletion?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on T-cell depletion.